Baranwal Drug Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth -22.00%
(FY 2022)
- Total Assets 124.63%
(FY 2022)
About Baranwal Drug
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priti Barnwal and Surendra Barnwal serve as directors at the Company.
- CIN/LLPIN
U24100DL2019PTC353430
- Company No.
353430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2019
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Baranwal Drug?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priti Barnwal  | Director | 22-Feb-2024 | Current |
| Surendra Barnwal | Director | 05-Aug-2019 | Current |
Financial Performance of Baranwal Drug.
Baranwal Drug Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Baranwal Drug?
Unlock access to Baranwal Drug's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hurovet Pharma International Private LimitedActive 4 years 3 monthsPriti Barnwal and Surendra Barnwal are mutual person
- Jangliram International Private LimitedActive 4 years 8 days
Priti Barnwal and Surendra Barnwal are mutual person
- Holistic Unique Bharat Private LimitedActive 3 years 2 months
Priti Barnwal and Surendra Barnwal are mutual person
- Catalyst Publication Private LimitedActive 3 years 21 days
Priti Barnwal and Surendra Barnwal are mutual person
- Sunwiz Science Laboratory Biotech India Private LimitedActive 5 years 6 months
Priti Barnwal and Surendra Barnwal are mutual person
- Dehati Cafe And Restaurant Private LimitedActive 3 years 2 months
Priti Barnwal and Surendra Barnwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Baranwal Drug?
Unlock and access historical data on people associated with Baranwal Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baranwal Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baranwal Drug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
